Circulating cytokine levels in Chagas patients with and without dilated cardiomyopathy
; Sosa, Gustavo ; Lombardi, María Gabriela
; Von Wulffen, Alejandra ; Campi, Natalia ; Paolucci, Analia ; Principato, Mario Bruno ; Carbajales, Justo ; Di Girolamo, Guillermo 
Otros responsables
Fecha
2019
Editorial
Fundación Revista Medicina
Revista
Título del libro
Nombre del evento
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento
2019-11-13
Institución organizadora
Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
ISSN
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Reunión
Clasificación temática
Palabras clave
Resumen
Dilated cardiomyopathy (DC) represents the most severe manifestation that affects ≈30% of individuals along 10-30 years after T. cruzi infection. To study the underlying mechanisms, circulating levels of different cytokines/chemokines were investigated in patients with DC or not (NC) and compared with healthy control donors (C).Chagas´ patients were recruited by the Cardiogenetic Center, Ramos Mejía Hospital, Bs. As., after signing the informed consent approved by the local Ethics Committee. All patients came from northwestern Argentina and southern Bolivia. No patient presented another etiology of dilated cardiomyopathy except Chagas. Enrolled patients were submitted to a standard follow up and clinical treatment. The NC group (n=22) included asymptomatic individuals, with ejection fraction (EF) more than 50 % and DC group (n=22) showed EF less than 35%. Normal healthy volunteers showing negative serological tests for the infection were included as the (C) group (n=14). Fasting plasma levels of IFNγ, IL-1β, IL-6, IL-10, IL-12 (p70), IL-15, IL-17A, MCP-1/CCL2, MIP-1alpha/CCL3, TNFalpha and IL-2 were assessed using a Magnetic Bead Multiplex Assay in a Magpix® equipment (Merck Millipore). Concentrations were determined using the xPONENT software version 4.2.Our results showed that: 1- DC, in contrast to NC, had higher levels of TNFalpha than C (p: 0.010), 2- IL-6 concentration increased in DC with respect to NC (p: 0.033), 3- NC showed a trend to higher MCP-1 levels respect to DC (p: 0.119), 4-no differences were observed in the rest of the analyzed cytokines. These data suggest that IL-17A producing cells (IL3 and Th17) and INF-γ producers (NK, Tc, Th1 cells) have a little contribution in this phase of the disease. The present observations agree with the similar levels of IL-2, IL-12p70 and IL-15 found in all groups. In contrast, IL-6 and TNFalpha, likely derived from monocytes/macrophages, would contribute to cardiac inflammation and dysfunction in Chagas disease.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
